baber/WOPTO huggingface dataset:
Patent NZ-514606-A (NZ)
Title: Recombinant haemophilus influenzae adhesin proteins
Inventor: LOOSMORE SHEENA M
IPC: A61P31/04
Filed: 2000-03-16
Abstract: Recombinant production of Hia protein, in full-length and N-terminally truncated forms, of non-typeable strains of Haemophilus influenzae, is described. The nucleic acid and deduced amino acid sequences of Hia genes of various strains of non-typeable and type c Haemophilus influenzae also are described
Patent NZ-515592-A (NZ)
Title: Apparatus for deriving energy from waves
Inventor: KEMP JOHN FREDERICK
IPC: B63B35/00
Filed: 2001-02-28
Abstract: The apparatus has a chamber 1 adapted to float in water but having a water plane area such that its vertical oscillating movement is substantially damped relative to the height of waves in the water in which it is floating, a chamber inlet port (5) at one end of the chamber adapted to face into a wavetrain, and vertical side plates (7A,7B) delivering compressed air to a manifold and thence to an outlet port (9) and a baffle (8).
Patent NZ-516100-A (NZ)
Title: Streptogramin derivatives, preparation and compositions containing them
Inventor: ACHARD DANIEL
IPC: C07K5/078
Filed: 2000-06-29
Abstract: A group A streptogramin derivative or a pharmaceutically acceptable salt thereof has the formula (I) wherein: R1 is halogen, azido or thiocyanato; R2 is hydrogen, methyl or ethyl and R3 is hydrogen or a residue of an optionally substituted aliphatic, cycloaliphatic, aromatic, araliphatic, heterocyclic or heterocyclyl-aliphatic ester. The compounds are useful as antibacterial agents.
Patent NZ-519424-A (NZ)
Title: Caspase inhibitors and uses thereof
Inventor: GOLEC JULIAN
IPC: C07D209/46
Filed: 2000-12-08
Abstract: A 2-oxo-2H-quinoline or 2-oxo-1,4-dihydro-2H- quinazoline derivative has the formula (I) wherein: R1 is hydrogen, CN, CHN2, R or -CH2Y; R is an optionally substituted aliphatic group, aryl group, aralkyl group or non-aromatic heterocyclic group; Y is an electronegative leaving group, -OR, -SR, -OC(=O)(R) or -OPO(R8)(R9); R8 and R9 are independently R or OR; R2 is CO2H, CH2CO2H or esters, amides or isosteres thereof; R3 is hydrogen or alkyl; Ring A is fused Ring B and Ring B is an optionally saturated five to seven membered ring containing zero to three heteroatoms; X3 in Ring A is nitrogen or carbon wherein X3 with suitable valence may bear a substituent; each carbon with suitable valence in Ring A and Ring B is independently substituted by hydrogen, halo, R, OR, SR, OH, NO2, CN, NH2, NHR, N(R)2, NHCOR, NHCONHR, NHCON(R)2, NRCOR, NHCO2R, CO2R, CO2H, COR, CONHR, CON(R)2, S(O)2R, SONH2, S(O)R, SO2NHR, NHS(O)2R, =O, =S, =NNHR, =NNR2, =N-OR, =NNHCOR, =NNHCO2R, =NNHSO2R, or =NR and each substitutable nitrogen in Ring A is substituted by hydrogen, R, COR, S(O)2R, or CO2R; provided that when X3 is a carbon, a substituent on X3 is attached by an atom other than nitrogen. A pyridine derivative has formula (IA) wherein: R1 is CH2F, R2 is CO2H, and a) R3 to R7 are H; b) R3 is Me and R4 to R7 are H; c) R4 is Me and R3 and R5 to R7 are H; d) R6 is Ph and R3, R3 to R5 and R7 are H or e) R4 is Et, R7 is Ph and R3, R3, R5 and R6 are H. The compounds are useful as caspase inhibitors and are useful for treating diseases where caspase activity is implicated such as an IL-1 mediated disease, an apoptosis mediated disease, an inflammatory disease, an autoimmune disease, a destructive bone disorder or a proliferative disorder.
Patent NZ-519609-A (NZ)
Title: Soil Moisture Content Measurement System and Method
Inventor: EKANAYAKE JAGATH CHANDRALAL
IPC: G01N33/24
Filed: 2002-06-17
Abstract: A soil moisture content measurement system comprises: a porous plate arranged to support a soil sample; a hanging water tube extending downwardly from the porous plate, the tube arranged to convey liquid toward and away from the porous plate; a measuring capillary tube in connection with the hanging water tube, the measuring capillary tube arranged to convey liquid toward and away from the hanging water tube, the measuring capillary tube arrange to be raised and/or lowered with respect to the soil sample; measurement apparatus configured to measure the movement of liquid within the measuring capillary tube and a data memory configured to receive and store data from the measurement apparatus representing liquid movement measurements within the measuring capillary tube.
Patent NZ-527367-A (NZ)
Title: Pyrimidine derivatives for inhibition of cell-proliferation
Inventor: THOMAS ANDREW PETER
IPC: C07D487/04
Filed: 2002-02-12
Abstract: Compounds of the formula (I), pharmaceutically acceptable salts and in vivo hydrolysable esters are described. Also described are processes for their preparation and their use as medicaments, particularly medicaments for producing a cell cycle inhibitory (anti-cell-proliferation) effect in a warm-quest-blooded animal, such as man. In particular, the compounds are useful in the treatment of cancers (solid tumours and leukemias), fibroproliferative and differentiative disorders, psoriasis, rheumatoid arthritis, Kaposi's sarcoma, haemangioma, acute and chronic nephropathies, atheroma, atherosclerosis, arterial restenosis, autoimmune diseases, acute and chronic inflammation, bone diseases and ocular diseases with retinal vessel proliferation.
Patent NZ-528622-A (NZ)
Title: Methods for preparing vitamin D derivatives that are useful for treating psoriasis
Inventor: MORIKAWA KAZUMI
IPC: C07C235/06
Filed: 2001-06-14
Abstract: Preparation of a compound of formula (3) by a method of carbonylating a compound of formula (2) in a solvent in the presence of an organoaluminum reagent that may be represented as (R15)nAlW3-n and a palladium catalyst under a carbon monoxide atmosphere is disclosed, wherein: R12 and R13 each represent a protecting group; R14 represents a leaving group; R15 represents an alkyl group, an aryl group, an alkenyl group or an alkynyl group; W represents a halogen atom; and n represents an integer of 1 to 3. The compound of formula (3) may be used in the preparation of Vitamin D derivatives that are useful as therapeutic agents for skin diseases such as psoriasis, and that have a reduced hypercalcemic effect. (62) Divided out of 522853
Patent NZ-529853-A (NZ)
Title: Carbon tiles with refractory coating for use at elevated temperature
Inventor: DURUZ JEAN-JACQUES
IPC: C25C3/12
Filed: 2002-05-28
Abstract: A method of bonding a protective coating on a wear-exposed surface of a carbon tile comprises: applying onto the wear-exposed surface of the carbon tile at least one layer of a slurry of particulate refractory material suspended in a colloidal and/or inorganic polymeric carrier comprising a dispersion of colloidal particles and/or a solution of inorganic polymeric particles of binding metal oxide; and heat treating the slurry-applied layer(s) to consolidate the particulate refractory material in the binding metal oxide to form the protective coating. A hydrophobic carbon compound having a hydrophilic substituent, such as -OH, -SO3Na or -COOH, is used in the slurry as a bonding agent that bonds the binding metal oxide to the carbon tile by being bonded to the wear-exposed surface of the carbon tile and by having its hydrophilic substituent bonded to the binding metal oxide. Preferably, the protective coating comprises on the layer(s) containing the hydrophobic carbon compound one or more layers of refractory material which are substantially free of any elemental carbon or organic carbon compound.
Patent NZ-531511-A (NZ)
Title: Novel benzothiazine derivatives, their preparation and use
Inventor: GOULIAEV ALEX HAAHR
IPC: A61P25/08
Filed: 2002-10-02
Abstract: Benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy. This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy.
Patent NZ-532839-A (NZ)
Title: Pillowtop/panel attachment gusset with ruffled corners
Inventor: FREEMAN WILLIAM
IPC: A47C27/05
Filed: 2002-09-30
Abstract: Disclosed is an attachment gusset with ruffled corners and method and machinery for manufacture of the gusset. Gusset 18 is formed of a continuous strip of material which has pleats 32 at corners to form ruffles 34 which are attached to an adjacent layer of material 12,14. The ruffled gusset lies substantially flat against adjacent layers of material to which it is attached in a pressed state, and can be expanded to accommodate dimensional structures, such as cushioned pads. The number and spacing of pleats can be adjusted according to the radius of the corners or turns in the gusset. In a method of construction of the gusset, the pleats are formed as the material to which the gusset is attached is turned relative to the sewing point of attachment.
Patent NZ-533057-A (NZ)
Title: N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Inventor: CRESCENZI BENEDETTA
IPC: A61K31/515
Filed: 2002-10-21
Abstract: A compound of Formula (I) is disclosed. Pharmaceutical compositions comprising these compounds are also described. These compounds are useful in the manufacture of a medicament for inhibiting HIV integrase in a subject in need thereof. They are also useful in the manufacture of a medicament for preventing or treating infection by HIV or for preventing, treating or delaying the onset of AIDS in a subject in need thereof. A combination useful for treating or preventing infection by HIV, or for preventing, treating or delaying the onset of AIDS, which is a therapeutically effective amount of a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of an antiviral selected from the group consisting of HIV protease inhibitors, non-nucleoside HIV reverse transcriptase inhibitors and nucleoside HIV reverse transcriptase inhibitors, is also described.
Patent NZ-536830-A (NZ)
Title: Gutter mesh with arrays of ribs and heavier ribs
Inventor: WICKETT BRUCE
Filed: 2004-11-25
Abstract: A thermoplastic mesh is of the type which is affixed over guttering to prevent ingress of debris and has two arrays of flexible ribs perpendicular to each other so as to form apertures. The mesh also has a third array of heavier reinforcing ribs intended to lie parallel to the guttering direction which are spaced apart 20 to 50 mm with the top of each reinforcing rib not protruding above the upper surface of the mesh and each heavier rib being between 3 and 6 mm wide.
Patent NZ-538522-A (NZ)
Title: Synthesis of epothilones, intermediates thereto, analogues and uses thereof
Inventor: DANISHEFSKY SAMUEL J
IPC: C07D493/04
Filed: 2003-08-22
Abstract: A method for the manufacture of epothilone compounds of formula (I), intermediates thereto, analogues and uses thereof are disclosed. These epothilone compounds are suitable for treating cancer.
Patent NZ-544103-A (NZ)
Title: Efficient haploid cell sorting for flow cytometer systems
Inventor: EVANS KENNETH M
IPC: C12N5/071
Filed: 2004-05-15
Abstract: A flow cytometry system and a method of using the system for sample processing is disclosed. The system sorts irradiatable sperm cells, which have been dyed with a fluorescent dye, by their fluorescence under electromagnetic radiation. The system includes a sheath fluid, which surrounds an irradiatable sperm sample, and an oscillator for forming a stream of droplets from the sample and sheath fluid. A laser irradiates the sperm cells so they emit fluorescence. A fluorescence detector detects the fluorescence, then a processor and a drop charge circuit differentiate the sperm by applying charges to the droplets based on fluorescence. The sperm are separated using two oppositely charged deflection plates, which deflect the charged droplets into a sperm cell collector.
Patent NZ-561209-A (NZ)
Title: Biomaterial comprising collagen and a calcium phosphate material
Inventor: LYNN ANDREW K
IPC: A61L27/46
Filed: 2006-03-06
Abstract: Disclosed is a process for the preparation of a composite biomaterial comprising collagen and a calcium phosphate material, or collagen, a calcium phosphate material and a glycosaminoglycan, the process comprising: (a) providing a first slurry which has a liquid carrier, collagen, a calcium phosphate material and optionally a glycosaminoglycan and a second slurry composition comprising a liquid carrier, collagen, and optionally a calcium phosphate material and optionally a glycosaminoglycan; (b) providing a mould for the slurry; (c) depositing the first and second slurries in the mould; (d) cooling the slurry deposited in the mould to a temperature at which the liquid carrier transforms into a plurality of solid crystals or particles; (e) removing at least some of the plurality of solid crystals or particles by sublimation and/or evaporation to leave a porous composite material comprising collagen, a calcium phosphate material, and optionally a glycosaminoglycan; and (f) removing the material from the mould. Also disclosed is the biomaterial made from the process with can be used for repairing interfaces between tissues and a synthetic bone material, bone implant, bone graft, bone substitute, bone scaffold, filler, coating or cement comprising the biomaterial and a layered bone scaffold comprising the biomaterial used in tissue engineering.
Patent NZ-561327-A (NZ)
Title: Lighting system having magnetically attached plates
Inventor: LIDDLE RICHARD
IPC: F21S10/00
Filed: 2006-02-07
Abstract: Disclosed is a movable lighting element using magnetic plates. The lighting element (1) comprises at least one light (3), means for delivering electricity to each light (12, 13), a pair of spaced apart plates (2, 2'), at least one magnet (4) located between the plates, and biasing means (8) for biasing the plates apart. The magnet is attached to a first plate (2) of the pair of plates and movable relative to a second (2') of the pair of plates. The first plate is adapted to move towards the second plate against a biasing force generated by the biasing means, when a magnet having a polarity opposing that of the magnet attached to the first plate is presented up to and aligned therewith.
Patent NZ-561860-A (NZ)
Title: Versatile leg for a roof rack
Inventor: HUBBARD PETER DOUGLAS
IPC: B60R9/04
Filed: 2007-09-24
Abstract: A leg 20 for a roof rack is adaptable so as to be attachable to different mounting systems by which the leg can be attached to a vehicle, and includes a pair of supports 21a, 21b joined by a bridge 27 that supports a cross-bar housing 23. The supports have opposed inner faces on which mounting system locating elements 25, 28, 29 are situated for locating a mounting system in the correct position on the leg. The leg also includes an attachment system 22 by which one or more components of the mounting system can attach to the leg.
Patent NZ-572940-A (NZ)
Title: Prostate stem cell antigen (PSCA) variants and subsequences thereof
Inventor: JAKOBOVITS AYA
IPC: C12N5/095
Filed: 2004-05-28
Abstract: Provided is a recombinant viral vector comprising a specified sequence of PSCA protein, or a variant or functional fragment thereof. Further provided are in vitro methods of detecting the specified PSCA proteins. The vector can be used to induce an immune response. (62) Divided Out of 543840
Patent NZ-577179-A (NZ)
Title: Powder formulation for valganciclovir
Inventor: BACHYNSKY MARIA OKSANA
IPC: A61K31/522
Filed: 2007-12-03
Abstract: Disclosed herein is a solid pharmaceutical dosage form for oral administration, after being constituted in water, comprising: a) a therapeutically effective amount of valganciclovir hydrochloride; and b) fumaric acid present in an amount sufficient to stabilize the valganciclovir hydrochloride in water. Said dosage form is useful in the treatment of herpes simples virus and cytomegalovirus mediated diseases.
Patent NZ-577362-A (NZ)
Title: Determining the muzzle velocity by measuring signals generated by operating waveguide at certain frequency
Inventor: FRICK HENRY
IPC: G01P3/42
Filed: 2007-10-19
Abstract: A method and apparatus (100) for determining or measuring a muzzle velocity of a projectile is disclosed. In one of the embodiments, the measurement apparatus (100) comprises a gun barrel (1) with a muzzle brake (3) and an oscillator (4). The oscillator (4) is electrically connected via a signal supply (5) to a transmission coupler (6), in order to excite it. A reception coupler (7) is used for signal reception and is connected via a cable (8) to a receiving unit (9). The receiving unit (9) comprises a detector (9.1) and signal processor (9.2). The two couplers (6, 7) are integrated in the muzzle brake and form a couple pair. The oscillator (4) excites the barrel and muzzle brake, which acts as a waveguide (1, 3), via the transmission coupler (6). The frequency indicates the frequency below which waves are attenuated rather than propagated through the waveguide (1, 3). The muzzle velocity of the projectile is determined from measurements of the electromagnetic signal generated in response to the operation of the waveguide (1, 3).
Patent NZ-578544-A (NZ)
Title: A spooler with low friction spacers and an adjustable tension brake
Inventor: BOARDMAN ROBERT ERNEST
IPC: A01K89/00
Filed: 2007-12-05
Abstract: Disclosed is a spooler which consists of a base member and a shaft attached to the base member. The shaft has a longitudinal flat section at its free end. The spooler also includes a D washer, a spring and a retaining nut mounted on the free end of the shaft to retain and to brake the rotation of a spool. A low friction spacer is mounted on the shaft between the spool and the base member and a low friction spacer is mounted between the spool and the D washer.
Patent NZ-590618-A (NZ)
Title: Dosing device and method for filling a cavity
Inventor: DAGSLAND ALLAN
IPC: B65B1/24
Filed: 2009-08-13
Abstract: A dosing device 1 comprises a powder hopper 2 and a plate 11 with a surface 3 provided with cavities 5 for receiving a particulate material dispensed onto the plate surface from the hopper. A filling means such as a wheel 6 is movable along said surface 3 for moving particulate material into the cavities 5 from the surface. The wheel 6 is biased toward the plate surface to exert a compressing force on said particulate material in a direction towards said surface so that said particulate material is forced into the cavities 5. Scrapers 14 may be provided to agitate the powder on the surface that has not been filled into a cavity as the wheel goes by.
Patent NZ-593376-A (NZ)
Title: Kit and composition for eyelash growth
Inventor: BEDDINGFIELD FREDERICK C
IPC: A61K8/42
Filed: 2009-12-01
Abstract: 593376 Disclosed is a method of enhancing the growth of eyelashes in a person, comprising: opening a sterile sheath comprising a first sterile applicator brush and a second sterile applicator brush packaged together therein; dispensing a drop of sterile bimatoprost solution onto the first sterile applicator brush; applying the bimatoprost solution using the first sterile applicator brush across an eyelid margin of a first eye of the person; optionally disposing of the first sterile applicator brush after application of the bimatoprost solution to the eyelid margin, and optionally repeating the above steps with the second sterile applicator brush on an eyelid margin of a second eye of the person. Also disclosed is a method as defined above, wherein the sterile container contains a solution of 0.03% bimatoprost, and wherein the sterile applicator brush is configured to deliver about 2% to about 8% of the drop of bimatoprost to the eyelid margin, and wherein the amount of bimatoprost applied per eyelid margin is 5-12 ?g.
Patent NZ-599594-A (NZ)
Title: Fast dissolving solid dosage form
Inventor: LIM CHIN BENG STEPHEN
IPC: A61K9/20
Filed: 2010-10-26
Abstract: Disclosed is a fast dissolving solid dosage form for the release of a biologically active therapeutic material in an oral cavity wherein said dosage form comprises: a) a biologically active material; and b) a matrix forming agent comprising between 2 and 20% purified amylopectin by dry weight of the solid dosage form, and optionally a second matrix forming agent such as sodium carboxymethylcellulose, microcrystalline cellulose, glycine or mannitol; wherein said dosage form substantially dissolves in the oral cavity in less than 1 minute without leaving a residue of said dosage form in the oral cavity that is detectable by a subject. Also disclosed is a method of producing a fast dissolving solid dosage form for the release of a biologically active therapeutic material in an oral cavity, comprising the steps of: i) combining a matrix forming agent comprising between 2 and 20% purified amylopectin by dry weight of the solid dosage form with a biologically active material to form a homogeneous mixture; and ii) freeze drying the mixture to form the solid dosage form wherein said dosage form substantially dissolves in the oral cavity in less than 2 minutes without leaving a residue of said dosage form in the oral cavity that is detectable by a subject.
Patent NZ-599981-A (NZ)
Title: Decoding of multichannel audio encoded bit streams using adaptive hybrid transformation
Inventor: RAMAMOORTHY KAMALANATHAN
IPC: G10L19/02
Filed: 2010-10-28
Abstract: Disclosed is a method for decoding a frame of an encoded digital audio signal. The frame comprises frame metadata, a first audio block (AB0) and one or more subsequent audio blocks (AB1-ABn) and each of the first and subsequent audio blocks (AB0-ABn) includes block metadata and encoded audio data for two or more audio channels (CH0-CH2). The encoded audio data comprises scale factors and scaled values representing spectral content of the two or more audio channels (CH0-CH2), each scaled value being associated with a respective scale factor. The block metadata includes control information describing coding tools used by an encoding process that produced the encoded audio data, the coding tools including adaptive hybrid transform processing. The adaptive hybrid transform processing includes applying an analysis filter bank implemented by a primary transform to the two or more audio channels (CH0-CH02) to generate primary transform coefficients, and applying a secondary transform to the primary transform coefficients for at least some of the two or more audio channels (CH0-CH02) to generate hybrid transform coefficients. The method includes receiving the frame of the encoded digital audio signal and examining the encoded digital audio signal of the frame in a single pass to decode the encoded audio data for each audio block (AB1-ABn) in order by block. The decoding of each respective audio block (AB1-ABn) includes determining for each respective channel of the two or more channels (CH0-CH02) whether the encoding process used adaptive hybrid transform processing to encode any of the encoded audio data. If the encoding process used adaptive hybrid transform processing for the respective channel (CH0-CH02) and if the respective audio block (AB0-ABn) is the first audio block (AB0) in the frame ration then all hybrid transform coefficients of the respective channel (CH0-CH02) for the frame from the encoded audio data in the first audio block (AB0) are obtained. An inverse secondary transform is applied to the hybrid transform coefficients to obtain inverse secondary transform coefficients and primary transform coefficients are obtained from the inverse secondary transform coefficients for the respective channel (CH0-CH02) in the respective audio block (AB0-ABn). If the encoding process did not use adaptive hybrid transform processing for the respective channel (CH0-CH02), primary transform coefficients for the respective channel (CH0-CH02) are obtained by decoding the encoded data in the respective audio block (AB0-ABn) and an inverse primary transform is applied to the primary transform coefficients to generate an output signal representing the respective channel (CH0-CH02) in the respective audio block (AB0-ABn).